The global cardiac amyloidosis treatment market is experiencing significant expansion due to the increasing prevalence of this life-threatening heart condition worldwide. Additionally, advancements in screening techniques and the development of novel therapies are stimulating market growth. The market is characterized by a fragmented landscape wit